You are currently viewing the summary.
See the full text- Join / Subscribe
- Buy article
- member account Enable
- Renew subscription
- Recommend a subscription to your library
- Help for librarians
Summary
the Scripps research Institute has appointed two eminent scientists to direct one of the largest private biomedical research institutions in the world. Scripps chemist Peter Schultz will serve as CEO while Steve Kay, former dean of the University of Southern California (USC), will serve as chairman. The announcement ends a contentious period between Scripps leadership and faculty who rioted a year ago when Scripps leaders tried to merge the Institute with USC. Schultz and Kay say they intend to marry the historic strength of the institute in fundamental research with a new focus on translational research aimed at transforming discoveries into drugs. If successful, the duo say, should stabilize long-term finances of the Institute.
0 Komentar